Press Releases

Our medical news may contain information about Shionogi products and is therefore intended for medical journalists and health care professionals only. By clicking through to see medical news, you are confirming that you are a medical journalist or healthcare professional.

  1. Jan
  2. Feb
  3. Mar
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug
  9. Sep
  10. Oct
  11. Nov
  12. Dec

September

22 Sep 2026 Release Medical News
Shionogi Announces European Commission Approval of Zokovea® (ensitrelvir) for Post-Exposure Prophylaxis of COVID-19

June

18 Jun 2026 Release Medical News
Shionogi and F2G announce positive topline results from global Phase 3 OASIS study evaluating oral olorofim versus AmBisome® followed by Standard of Care in patients with invasive aspergillosis

April

07 Apr 2026 Release Medical News
ESCMID Global 2026: Shionogi presents new real-world data highlighting clinical effectiveness of Fetroja/Fetcroja (cefiderocol) in MBL-producing Enterobacterales infections

March

25 Mar 2026 Release Medical News
Shionogi Announces Approval in Japan of a Supplemental Indication for XOCOVA® (Ensitrelvir Fumaric Acid) for the Post-Exposure Prophylaxis of COVID-19
19 Mar 2026 Release Medical News
Shionogi Announces First Patients Enrolled in Global Phase 2 Clinical Trial in Adults with Late-Onset Pompe Disease

Select Year

NP-EU-NP-0260 | June 2024